Catalio Capital Management is a multi-strategy investment firm specializing in breakthrough biomedical technology and healthcare innovation. Founded in 2020, the company invests in life sciences companies globally, targeting drugs, devices, diagnostics, and data-driven insights. Catalio leverages its network of world-class scientists and clinicians to identify and grow transformative technologies from inception to exit.
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →